研究について

新しい治療法の開発は当センターの重要な社会的使命であり、新治療法の臨床試験に積極的に取り組んでいます。また、患者さんから採取した検体（組織、血液）は、患者さんのご了解を得て、癌の本態解明や治療法開発のための研究に利用させていただいています。

現在当科で行っている臨床研究

1. 胸腺上皮性腫瘍に対するFDG-PETの有用性についての検討

2. JCOG1211 胸部薄切CT所見に基づくすりガラス影優位の cT1N0 肺癌に対する区域切除の非ランダム化検証的試験

3. JCOG1205/JCOG1206 高悪性度神経内分泌肺癌完全切除例に対するイリノテカン+シスプラチン療法とエトポシド+シスプラチン療法のランダム化比較試験

4. JCOG0804/WJOG4507L胸部薄切CT所見に基づく肺野型早期肺癌に対する縮小切除の検証的非ランダム化試験

5. JCOG0802/WJOG4607L肺野末梢小型非小細胞肺癌に対する肺葉切除と縮小切除(区域切除)の第III相試験

6. JCOG0707病理病期I期(T1>2センチメートル)非小細胞肺癌完全切除例に対する術後化学療法の臨床第III相試験

7. 肺神経内分泌性腫瘍、特に大細胞神経内分泌癌の生検における病理診断基準の確立のため多施設共同研究

8. JCOG2217：胸部薄切 CT 上すりガラス成分を伴う充実成分優位な非小細胞肺癌（＞2-3 cm）に対する肺葉切除と区域切除のランダム化比較試験

9. 2017年に外科治療を施行された肺癌症例のデータベース研究（肺癌登録合同委員会 第10次事業）

10. 肺がん手術が患者さんの運動耐容能に与える影響の調査(介入研究)

11. JCOG2109：80歳以上の高齢者肺野末梢小型非小細胞肺癌における区域切除 vs. 楔状切除のランダム化比較試験

12. NCDを用いた本邦における悪性胸膜中皮腫に対する根治術の有用性および予後予測因子の検討: 肺癌登録合同委員会　第12次事業

13. JCOG2012：病理病期II-IIIA期非小細胞肺癌に対する術後サーベイランスに関するランダム化比較試験

14. JCOG0707A1: 「病理病期I期（T1＞2 cm）非小細胞肺癌完全切除例に対する術後化学療法の臨床第III相試験」の附随研究 早期肺癌切除後の長期的転帰に関する観察研究

15. 2021年に外科治療を施行された肺癌症例の データベース研究: 肺癌登録合同委員会 第11次事業

16. 肺腺癌の多段階発がん過程における免疫環境と遺伝子異常の解析研究

17. JCOG1916：病理学的N2非小細胞肺癌に対する術後放射線治療に関するランダム化比較第III相試験

18. JCOG1906：胸部薄切CT所見に基づく早期肺癌に対する経過観察の単群検証的試験

19. JCOG1909：肺葉切除高リスク臨床病期IA期非小細胞肺癌に対する区域切除と楔状切除のランダム化比 較試験

20. 肺癌登録合同委員会：胸腺上皮性腫瘍の前方視的データベース研究

21. JCOG1708：特発性肺線維症（IPF）合併臨床病期I期非小細胞肺癌に対する肺縮小手術に関するランダム化比較第III相試験

22. 胸部腫瘍の臨床病理学的な特性と治療の効果・安全性等に関する研究

23. JCOG1413：臨床病期I/II期非小細胞肺癌に対する選択的リンパ節郭清の治療的意義に関するランダム化比較試験

24. JCOG1211 胸部薄切CT 所見に基づくすりガラス影優位の cT1N0肺癌に対する区域切除の非ランダム化検証的試験

25. JCOG0804/WJOG4507L胸部薄切CT所見に基づく肺野型早期肺癌に対する縮小切除の検証的非ランダム化試験

26. JCOG0802/WJOG4607L肺野末梢小型非小細胞肺癌に対する肺葉切除と縮小切除(区域切除)の第III相試験

27. 3Dセンサーを使用した、見守り支援サービスシステムの共同開発を目的とした実用性の研究

28. CLDN6陽性非小細胞肺癌に関する観察研究

29. pStage I期 非扁平上皮非小細胞肺がん外科切除例の術後再発予測する分子マーカーの探索（多施設後ろ向きバイオマー カー研究）

30. 原発性肺癌における解剖学的肺切除後の同側に発生した二次癌または肺内転移再発に対する手術療法と放射線療法の比較 に関する観察研究

31. 胸膜播種を伴う原発性肺癌に対する外科切除の意義に関する観察研究

32. 原発性肺癌の術前画像所見に基づく病理所見・予後の予測に関する観察研究

33. 原発性胸部悪性腫瘍に対する外科切除の長期的記録を用いた周術期成績と術後予後の観察研究

34. 転移性肺腫瘍に対する外科切除後の予後に関する観察研究

2023年度業績（2023年4月～2024年3月） 

雑誌論文（欧文）

1. Yano K, Yotsukura M, Watanabe H, AkamineT, Yoshida　Y, Nakagawa　K, Yatabe Y, Kusumoto M, Watanabe SI. Oncological feasibility of segmentectomy for inner-located lung cancer. JTCVS Open, April 2024;18時26分1-275, Published:February 28, 2024DOI:https://doi.org/10.1016/j.xjon.2024.02.015.
2. Detterbeck FC, Ostrowski M, Hoffmann H, Rami-Porta R, Osarogiagbon RU, Donnington J, Infante M, Marino M, Marom EM, Nakajima J, Nicholson AG, van Schil P, Travis WD, Tsao MS, Edwards JG, Asamura H; Members of the Staging and Prognostic Factors Committee and Advisory Boards.. The IASLC Lung Cancer Staging Project: Proposals for Revision of the Classification of Residual Tumor after Resection for the Forthcoming (9th) Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2024 Apr 1:S1556-0864(24)00129-1. PMID:38569931, DOI: 10.1016/j.jtho.2024.03.021. Online ahead of print.
3. Sakashita M, Motoi N, Yamamoto G, Gambe E, Suzuki M, Yoshida Y, Watanabe SI, Takazawa Y, Aoki K, Ochiai A, Sakashita S. An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections. J Cancer Res Clin Oncol. 2024 Apr 3;150(4):172. PMID: 38565653 DOI: 10.1007/s00432-024-05653-1.
4. Gill RR, Nowak AK, Giroux DJ, Eisele M, Rosenthal A, Kindler H, Wolf A, Ripley RT, Billé A, Rice D, Opitz I, Rimner A, dePerrot M, Pass HI, Rusch VW; IASLC Staging and Prognostic Factors Committee; Advisory Boards and Participating Institution. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the 'T' Descriptors in the Forthcoming 9th Edition of the TNM Classification for Pleural Mesothelioma. J Thorac Oncol. 2024 Mar 21:S1556-0864(24)00086-8. PMID:38521202, DOI: 10.1016/j.jtho.2024.03.007. Online ahead of print.
5. Takasawa K, Asada K, Kaneko S, Shiraishi K, Machino H, Takahashi S, Shinkai N, Kouno N, Kobayashi K, Komatsu M, Mizuno T, Okubo Y, Mukai M, Yoshida T, Yoshida Y, Horinouchi H, Watanabe SI, Ohe Y, Yatabe Y, Kohno T, Hamamoto R. Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability. Exp Mol Med. 2024 Mar;56(3):646-655. doi: 10.1038/s12276-024-01173-7. Epub 2024 Mar 4. PMID: 38433247, PMCID: PMC10985003 DOI: 10.1038/s12276-024-01173-7.
6. Fukuda H, Arai K, Mizuno H, Nishito Y, Motoi N, Arai Y, Hiraoka N, Shibata T, Sonobe Y, Kayukawa Y, Hashimoto E, Takahashi M, Fujii E, Maruyama T, Kuwabara K, Nishizawa T, Mizoguchi Y, Yoshida Y, Watanabe SI, Yamashita M, Kitano S, Sakamoto H, Nagata Y, Mitsumori R, Ozaki K, Niida S, Kanai Y, Hirayama A, Soga T, Tsukada K, Yabuki N, Shimada M, Kitazawa T, Natori O, Sawada N, Kato A, Yoshida T, Yasuda K, Ochiai A, Tsunoda H, Aoki K. Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments. Cancer Sci. 2024 Mar 25. doi: 10.1111/cas.16154. Online ahead of print. PMID: 38527308 DOI: 10.1111/cas.16154.
7. Rami-Porta R, Nishimura KK, Giroux DJ, Detterbeck F, Cardillo G, Edwards JG, Fong KM, Giuliani M, Huang J, Kernstine KH Sr, Marom EM, Nicholson AG, Van Schil PE, Travis WD, Tsao MS, Watanabe SI, Rusch VW, Asamura H; Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024 Mar 4:S1556-0864(24)00079-0. PMID:38447919. DOI: 10.1016/j.jtho.2024.02.011 . Online ahead of print.
8. Mochizuki A, Shiraishi K, Honda T, Higashiyama RI, Sunami K, Matsuda M, Shimada Y, Miyazaki Y, Yoshida Y, Watanabe SI, Yatabe Y, Hamamoto R, Kohno T. Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis. J Thorac Oncol. 2024 Feb 19:S1556-0864(24)00074-1. doi: 10.1016/j.jtho.2024.02.006. Online ahead of print.　 PMID: 38382595 DOI: 10.1016/j.jtho.2024.02.006.
9. Shiraishi K, Takahashi A, Momozawa Y, Daigo Y, Kaneko S, Kawaguchi T, Kunitoh H, Matsumoto S, Horinouchi H, Goto A, Honda T, Shimizu K, Torasawa M, Takayanagi D, Saito M, Saito A, Ohe Y, Watanabe SI, Goto K, Tsuboi M, Tsuchihara K, Takata S, Aoi T, Takano A, Kobayashi M, Miyagi Y, Tanaka K, Suzuki H, Maeda D, Yamaura T, Matsuda M, Shimada Y, Mizuno T, Sakamoto H, Yoshida T, Goto Y, Yoshida T, Yamaji T, Sonobe M, Toyooka S, Yoneda K, Masago K, Tanaka F, Hara M, Fuse N, Nishizuka SS, Motoi N, Sawada N, Nishida Y, Kumada K, Takeuchi K, Tanno K, Yatabe Y, Sunami K, Hishida T, Miyazaki Y, Ito H, Amemiya M, Totsuka H, Nakayama H, Yokose T, Ishigaki K, Nagashima T, Ohtaki Y, Imai K, Takasawa K, Minamiya Y, Kobayashi K, Okubo K, Wakai K, Shimizu A, Yamamoto M, Iwasaki M, Matsuda K, Inazawa J, Shiraishi Y, Nishikawa H, Murakami Y, Kubo M, Matsuda F, Kamatani Y, Hamamoto R, Matsuo K, Kohno T. Identification of telomere maintenance gene variations related to lung adenocarcinoma risk by genome-wide association and whole genome sequencing analyses. Cancer Commun (Lond). 2024 Feb;44(2):287-293. PMID: 37882647 PMCID: PMC10876189 DOI: 10.1002/cac2.12498 Epub 2023 Oct 26.
10. Takamori S, Yatabe Y, Osoegawa A, Aokage K, Yoshioka H, Miyoshi T, Mimae T, Endo M, Hattori A, Yotsukura M, Isaka T, Isaka M, Maniwa T, Nakajima R, Watanabe SI. Rare but clinically important salivary gland-type tumor of the lung: A review. Jpn J Clin Oncol. 2024 Feb 7;54(2):121-128. PMID: 37952098 DOI: 10.1093/jjco/hyad154.　
11. Kobayashi K, Gu L, Hataya R, Mizuno T, Miyake M, Watanabe H, Takahashi M, Takamizawa Y, Yoshida Y, Nakamura S, Kouno N, Bolatkan A, Kurose Y, Harada T, Hamamoto R. Sketch-based semantic retrieval of medical images. Med Image Anal. 2024 Feb;92:103060. doi: 10.1016/j.media.2023.103060. Epub 2023 Dec 8.
12. Mochizuki A, Shiraishi K, Honda T, Higashiyama RI, Sunami K, Matsuda M, Shimada Y, Miyazaki Y, Yoshida Y, Watanabe SI, Yatabe Y, Hamamoto R, Kohno T. Passive Smoking-Induced Mutagenesis as a Promoter of Lung Carcinogenesis. J Thorac Oncol. 2024 Feb 19:S1556-0864(24)00074-1.
13. Sugawara H, Kikkawa N, Ito K, Watanabe H, Kaku S, Akai H, Abe O, Watanabe SI, Yatabe Y, Kusumoto M. Is 18F-fluorodeoxyglucose PET recommended for small lung nodules? CT findings of 18F-fluorodeoxyglucose non-avid lung cancer. Br J Radiol. 2024 Feb 2;97(1154):462-468. PMID:38308036, DOI: 10.1093/bjr/tqad048.
14. Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y, Yatabe Y, Kusumoto M, Watanabe SI. ASO Visual Abstract: Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. Ann Surg Oncol 2024 Feb;31(2):1146-1147. PMID: 37843666 DOI: 10.1245/s10434-023-14391-6.
15. Hattori A, Suzuki K, Takamochi K, Wakabayashi M, Sekino Y, Tsutani Y, Nakajima R, Aokage K, Saji H, Tsuboi M, Okada M, Asamura H, Nakamura K, Fukuda H, Watanabe SI; Japan Clinical Oncology Group; West Japan Oncology Group. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial. Lancet Respir Med. 2024 Feb;12(2):105-116. PMID: 38184010 DOI: 10.1016/S2213-2600(23)00382-X. Epub 2024 Jan 3.
16. Ohashi K, Nishito Y, Fukuda H, Sadahiro R, Yoshida Y, Watanabe SI, Motoi N, Sonobe Y, Mizuno H, Tsunoda H, Tatsumi K, Suzuki T, Ochiai A, Aoki K. Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer. Sci Rep. 2024 Jan 3;14(1):429. PMID:38172491. PMCID:PMC10764784. DOI: 10.1038/s41598-023-50378-9.
17. Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y, Yatabe Y, Kusumoto M, Watanabe SI. Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. Ann Surg Oncol. 2024 Jan;31(1):192-200. PMID: 37743455 DOI: 10.1245/s10434-023-14328-z. Epub 2023 Sep 25.
18. Adachi H, Morohoshi T, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T, Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Benefit of Adjuvant Chemotherapy for Patients Older Than 75 Years With Completely Resected p-Stage II-IIIA Non-Small-Cell Lung Cancer: A Retrospective Cohort Study Using Japanese Nationwide Real-World Data. Clin Lung Cancer. 2024 Jan;25(1):61-71.e1. PMID: 37914595 DOI: 10.1016/j.cllc.2023.10.001. Epub 2023 Oct 12.
19. Adachi H, Saito A, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T, Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H, Japanese Joint Committee Of Lung Cancer Registry. Is adjuvant chemotherapy for completely resected p-stage IA (>2 cm) and stage IB non-small-cell lung cancer beneficial for elderly patients? A large, retrospective cohort study based on real-world data from Japan. Jpn J Clin Oncol. 2023 Dec 7;53(12):1191-1200. PMID: 37626449 DOI: 10.1093/jjco/hyad116.
20. Shirasawa M, Yoshida T, Shiraishi K, Goto N, Yagishita S, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Naoki K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Tumor microenvironment-mediated immune profiles and efficacy of anti-PD-L1 antibody plus chemotherapy stratified by DLL3 expression in small-cell lung cancer. Br J Cancer. 2023 Dec;129(12):2003-2013. PMID: 37731022. PMCID: PMC10703835 (available on 2024-09-20). DOI: 10.1038/s41416-023-02427-3. Epub 2023 Sep 20.
21. Haga Y, Sakamoto Y, Kajiya K, Kawai H, Oka M, Motoi N, Shirasawa M, Yotsukura M, Watanabe SI, Arai M, Zenkoh J, Shiraishi K, Seki M, Kanai A, Shiraishi Y, Yatabe Y, Matsubara D, Suzuki Y, Noguchi M, Kohno T, Suzuki A. Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma. Nat Commun. 2023 Dec 15;14(1):8375. PMID: 38102134 PMCID: PMC10724178 DOI: 10.1038/s41467-023-43732-y.
22. Miyoshi T, Ito H, Wakabayashi M, Hashimoto T, Sekino Y, Suzuki K, Tsuboi M, Moriya Y, Yoshino I, Isaka T, Hattori A, Mimae T, Isaka M, Maniwa T, Endo M, Yoshioka H, Nakagawa K, Nakajima R, Tsutani Y, Saji H, Okada M, Aokage K, Fukuda H, Watanabe SI. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer. Eur J Cardiothorac Surg. 2023 Dec 1;64(6):ezad365. PMID: 37930048 DOI: 10.1093/ejcts/ezad365.
23. Muraoka Y, Yotsukura M, Yoshida Y, Nakagawa K, Shiraishi K, Kohno T, Yatabe Y, Watanabe SI. Dynamics of recurrence after curative resection of nonsmall cell lung cancer. J Surg Oncol. 2023 Dec;128(7):1205-1212. PMID: 37458135 DOI: 10.1002/jso.27395.
24. Maniwa T, Okami J, Miyoshi T, Wakabayashi M, Yoshioka H, Mimae T, Endo M, Hattori A, Nakagawa K, Isaka T, Isaka M, Kita R, Sekino Y, Mitome N, Aokage K, Saji H, Nakajima R, Okada M, Tsuboi M, Asamura H, Fukuda H, Watanabe SI; West Japan Oncology Group; Japan Clinical Oncology Group. Lymph node dissection in small peripheral lung cancer: supplemental analysis of JCOG0802/WJOG4607L. J Thorac Cardiovasc Surg. 2023 Nov 22:S0022-5223(23)01099-1. PMID:38000629. DOI: 10.1016/j.jtcvs.2023.11.023. Online ahead of print.
25. Mimae T, Wakabayashi M, Sano Y, Sekino Y, Aokage K, Okada M, Watanabe SI, Saji H, the Lung Cancer Surgical Study Group/Japan Clinical Oncology Group. Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non-small cell lung cancer in 80 or more aged elderly patients: a randomized phase III study (JCOG2109, AWESOME). Japanese Journal of Clinical Oncology. 2023 Nov;53(11) : 1077–1081.
26. Okumura M, Yoshino I, Funaki S, Okuda K, Watanabe SI, Tsuboi M, Shimizu K, Date H, Chen-Yoshikawa TF, Nakajima J, Toyooka S, Asamura H. Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide database. Surg Today. 2023 Nov;53(11):1247-1259.　 PMID: 37460670. DOI: 10.1007/s00595-023-02705-w. Epub 2023 Jul 17.
27. Matsuura Y, Mun M, Shintani Y, Okami J, Ito H, Ohtsuka T, Mori T, Watanabe SI, Chida M, Endo S, Nakanishi R, Kadokura M, Suzuki H, Miyaoka E, Yoshino I, Date H; Japanese Joint Committee of Lung Cancer Registry. Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database. J Surg Oncol. 2023 Oct;128(5):916-924.　 PMID: 37403534. DOI: 10.1002/jso.27384. Epub 2023 Jul 5.
28. Yoshino I, Moriya Y, Suzuki K, Wakabayashi M, Saji H, Aokage K, Suzuki M, Ito H, Matsumoto I, Kobayashi M, Okamoto T, Okada M, Yamashita M, Ikeda N, Nakamura S, Kataoka T, Tsuboi M, Watanabe SI; West Japan Oncology Group and Japan Clinical Oncology Group. Long-term outcome of patients with peripheral ground-glass opacity-dominant lung cancer after sublobar resections. J Thorac Cardiovasc Surg. 2023 Oct;166(4):1222-1231.e1. PMID: 37704343 DOI: 10.1016/j.jtcvs.2023.01.019.
29. Igarashi T, Mazevet M, Yasuhara T, Yano K, Mochizuki A, Nishino M, Yoshida T, Yoshida Y, Takamatsu N, Yoshimi A, Shiraishi K, Horinouchi H, Kohno T, Hamamoto R, Adachi J, Zou L, Shiotani B. An ATR-PrimPol pathway confers tolerance to oncogenic KRAS-induced and heterochromatin-associated replication stress. Nat Commun. 2023 Aug 17;14(1):4991.
30. Takei H, Kunitoh H, Wakabayashi M, Kataoka T, Sekino Y, Mizutani T, Tsuboi M, Ikeda N, Asamura H, Okada M, Takahama M, Ohde Y, Okami J, Shiono S, Aokage K, Watanabe SI; Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group, Japan. Prospective, Multi-Institutional Observational Study of Deterioration in Activities of Daily Living in Elderly Patients After Lung Cancer Surgery. JTO Clin Res Rep. 2023 Jul 17;4(8):100550. PMID: 37600227. PMCID: PMC10432798. DOI: 10.1016/j.jtocrr.2023.100550. eCollection 2023 Aug.
31. Aoki K, Nishito Y, Motoi N, Arai Y, Hiraoka N, Shibata T, Sonobe Y, Kayukawa Y, Hashimoto E, Takahashi M, Fujii E, Nishizawa T, Fukuda H, Ohashi K, Arai K, Mizoguchi Y, Yoshida Y, Watanabe SI, Yamashita M, Kitano S, Sakamoto H, Nagata Y, Mitsumori R, Ozaki K, Niida S, Kanai Y, Hirayama A, Soga T, Maruyama T, Tsukada K, Yabuki N, Shimada M, Kitazawa T, Natori O, Sawada N, Kato A, Yoshida T, Yasuda K, Mizuno H, Tsunoda H, Ochiai A. Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations. Cancer Res Commun. 2023 Jun 13;3(6):1026-1040. PMID: 37377611. PMCID: PMC10263066. DOI: 10.1158/2767-9764.CRC-22-0415. eCollection 2023 Jun.
32. Adachi M, Matsumoto Y, Furuse H, Uchimura K, Imabayashi T, Yotsukura M, Yoshida Y, Nakagawa K, Igaki H, Watanabe SI, Tsuchida T. Utility of the endobronchial Watanabe spigot for intractable cancer-related pneumothorax: a retrospective observational study. Jpn J Clin Oncol. 2023 Aug 30;53(9):829-836. PMID: 37340759. PMCID: PMC10473273. DOI: 10.1093/jjco/hyad060.
33. Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial. Lancet Respir Med. Lancet Respir Med. 2023 Jun;11(6):540-549. PMID: 36893780. DOI: 10.1016/S2213-2600(23)00041-3.
34. Asamura H, Nishimura KK, Giroux DJ, Chansky K, Hoering A, Rusch V, Rami-Porta R; Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2023 May;18(5):564-575. PMID: 36773775. DOI: 10.1016/j.jtho.2023.01.088.
35. Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Dai J, Hung RJ, Chen K, Shu XO, Kim YT, Landi MT, Lin D, Zheng W, Yin Z, Zhou B, Song B, Wang J, Seow WJ, Song L, Chang IS, Hu W, Chien LH, Cai Q, Hong YC, Kim HN, Wu YL, Wong MP, Richardson BD, Funderburk KM, Li S, Zhang T, Breeze C, Wang Z, Blechter B, Bassig BA, Kim JH, Albanes D, Wong JYY, Shin MH, Chung LP, Yang Y, An SJ, Zheng H, Yatabe Y, Zhang XC, Kim YC, Caporaso NE, Chang J, Ho JCM, Kubo M, Daigo Y, Song M, Momozawa Y, Kamatani Y, Kobayashi M, Okubo K, Honda T, Hosgood DH, Kunitoh H, Patel H, Watanabe SI, Miyagi Y, Nakayama H, Matsumoto S, Horinouchi H, Tsuboi M, Hamamoto R, Goto K, Ohe Y, Takahashi A, Goto A, Minamiya Y, Hara M, Nishida Y, Takeuchi K, Wakai K, Matsuda K, Murakami Y, Shimizu K, Suzuki H, Saito M, Ohtaki Y, Tanaka K, Wu T, Wei F, Dai H, Machiela MJ, Su J, Kim YH, Oh IJ, Lee VHF, Chang GC, Tsai YH, Chen KY, Huang MS, Su WC, Chen YM, Seow A, Park JY, Kweon SS, Chen KC, Gao YT, Qian B, Wu C, Lu D, Liu J, Schwartz AG, Houlston R, Spitz MR, Gorlov IP, Wu X, Yang P, Lam S, Tardon A, Chen C, Bojesen SE, Johansson M, Risch A, Bickeböller H, Ji BT, Wichmann HE, Christiani DC, Rennert G, Arnold S, Brennan P, McKay J, Field JK, Shete SS, Marchand LL, Liu G, Andrew A, Kiemeney LA, Narui SZ, Grankvist K, Johansson M, Cox A, Taylor F, Yuan JM, Lazarus P, Schabath MB, Aldrich MC, Jeon HS, Jiang SS, Sung JS, Chen CH, Hsiao CF, Jung YJ, Guo H, Hu Z, Burdett L, Yeager M, Hutchinson A, Hicks B, Liu J, Zhu B, Berndt SI, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Wang WC, Xu J, Guan P, Tan W, Yu CJ, Yang G, Sihoe ADL, Chen Y, Choi YY, Kim JS, Yoon HI, Park, Xu IP, He Q, Wang CL, Hung HH, Roel C. H. Vermeulen RCH, Cheng I, Wu J, Lim WY, Tsai FY, Chan JKC, Li J, Chen H, Lin HC, Jin L, Liu J, Sawada N, Yamaji T, Wyatt K, Li SA, Ma H, Zhu M, Wang Z, Cheng S, Li X, Ren Y, Chao A, Iwasaki M, Zhu J, Jiang G, Fei K, Wu G, Chen CY, Chen CJ, Yang PC, Yu J, Stevens VL, Joseph F. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population, Nat Commun. Nat Commun. 2023 May 26;14(1):3043. PMID: 37236969. PMCID: PMC10220065. DOI: 10.1038/s41467-023-38196-z.
36. Higashiyama M, Motoi N, Yotsukura M, Yoshida Y, Nakagawa K, Yagishita S, Shirasawa M, Yoshida T, Shiraishi K, Kohno T, Ohe Y, Watanabe SI. Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma. Pathol Int. 2023 May;73(5):188-197. PMID: 36896472. DOI: 10.1111/pin.13316. Epub 2023 Mar 9.
37. Akamine T, Nakagawa K, Ito K, Watanabe H, Yotsukura M, Yoshida Y, Yatabe Y, Kusumoto M, Watanabe SI. Role of fluorine-18-fluorodeoxyglucose positron emission tomography in selecting candidates for a minimally invasive approach for thymic epithelial tumour resection. Interdiscip Cardiovasc Thorac Surg. 2023 May 4;36(5):ivad082. PMID: 37208183. PMCID: PMC10232332. DOI: 10.1093/icvts/ivad082.　
38. Shirasawa M, Yoshida T, Shiraishi K, Takigami A, Takayanagi D, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy. Lung Cancer. 2023 May;179:107183. PMID: 37037178. DOI: 10.1016/j.lungcan.2023.107183. Epub 2023 Mar 25.
39. Fujii H, Yamada Y, Yamamura K, Ishida Y, Tsujimura M, Matsumoto K, Tanaka S, Date H, Nishikawa T, Yoshida Y, Kashima J, Yatabe Y, Ogawa S, Marx A, Ulbright TM, Haga H. A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor. Virchows Arch. 2023 May;482(5):923-927.
40. Liu L, Aokage K, Chen C, Chen C, Chen L, Kim YH, Lee CY, Liu C, Liu CC, Nishio W, Suzuki K, Tan L, Tseng YL, Yotsukura M, Watanabe SI. Asia expert consensus on segmentectomy in non-small cell lung cancer: A modified Delphi study. JTCVS Open. 2023 Apr 7;14時48分3-501. PMID: 37425437. PMCID: PMC10328970. DOI: 10.1016/j.xjon.2023.03.013. eCollection 2023 Jun.
41. Takemura C, Imabayashi T, Furuse H, Uchimura K, Matsumoto Y, Tsuchida T, Watanabe SI. Thoracic SMARCA4-deficient undifferentiated tumor diagnosed by transbronchial mediastinal cryobiopsy: A case report. Case Reports. Thorac Cancer. 2023 Apr;14(10):953-957. PMID: 36828806. PMCID: PMC10067353. DOI: 10.1111月17日59-7714.14830 . Epub 2023 Feb 24.

雑誌論文（和文）

1．和文論文

1. 原著・総説
2. 竹村千尋,渡辺俊一．定期的区域切除における基本手技,胸部外科,77（10）,2024年9月号増刊．

 

2．著書・総説・Textbook

1. 渡辺俊一． (1) 出血時の初期対応（一時止血操作）, (2) PA 壁損傷部位の修復（二次止血操作）,総論2章　肺切除術における術中出血とその対策,呼吸器外科 morbidity and mortality conference 1版．須田隆　編, 株式会社南山堂．pp 18- 20, pp20-23, 2023年8月．発行地：東京．